CooperVision has announced their Best Practices Honorees for 2019!

Now in it’s fourth year, the CooperVision Best Practices Program recognizes and celebrates practices in the U.S. that elevate the profession through innovation, industry leadership and patient experience.

In this ODwire TV episode, Dr. Michele Andrews, Senior Director of Professional & Academic Affairs at CooperVision announces the 2019 Best Practices honorees and talks about the genesis of the program.

Watch the video and discuss with your peers.

At SECO 2019, we got a first look at Alcon's new iLux MGD treatment.

(That's Gretchyn Bailey of Optometry Times asking all the questions & demoing the device!)

Its big calling-card is that it is substantially cheaper than alternative devices, while being therapeutically equivalent.

Read all about it in this thread, and discuss with your peers.

I'm happy to announce the launch of a new product (and a new ODwire.org site sponsor), the AB Max!

It is the latest instrument designed to treat anterior blepharitis.

I got a first-look at the devicee at SECO, and spoke with the device's inventor, John Choate.

The comparison with the BlephEx is natural and obvious (John was one of the designers of the original), the big differences that I could see:

1) the device has a patent-pending "pulse mode", which is more comfortable for the patients and...

2) the cost -- the device itself is billed as 1/3rd the cost, and the consumables (ie, the tips) are priced at about 50% of other devices.

They are running a SECO special including the device, tips, patient literature, an i-Chek and a cute little demodex mite toy to show to patients.

If you have any questions, post them in this thread, or visit their web site, www.AB-Max.com, or call them at 1-800-721-8006.

Discussion:
https://www.odwire.org/community/threads/ab-max-the-newest-instrument-for-treating-anterior-blepharitis.118919/